Pharmaceuticals, Biotechnology and Life Sciences
Conference call at 4:30 p.m. Eastern time today WOBURN, Mass., Nov. 30, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI),…
Dr. Arron brings nearly two decades of scientific leadership in biotech drug discovery and development to 23andMe’s Therapeutics teamSUNNYVALE, Calif.,…
FREMONT, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the…
4th approved indication for toripalimabSHANGHAI, China, Nov. 30, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX:…
NEW HAVEN, Conn., Nov. 29, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical…
New capabilities increase efficiency in analyzing and developing small molecules and biologic drugsPRINCETON, N.J., Nov. 29, 2021 (GLOBE NEWSWIRE) —…
PITTSBURGH, Nov. 29, 2021 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), the leader in redosable gene therapies…
ISELIN, N.J., Nov. 29, 2021 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics”), a late clinical-stage biopharmaceutical company working to develop…
SAN DIEGO, Nov. 29, 2021 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product…
Seer Board of Directors Meeta Gulyani REDWOOD CITY, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a…